Lupin Limited moves closer to the Wakix market as pitolisant tentative approval sharpens future optionality
Lupin Limited has won tentative FDA approval for pitolisant tablets. Read why timing, exclusivity, and Wakix market dynamics matter next.
Pharma & Biotech
Pharma & Biotech
Is DOXA the multi-mechanism small molecule NewcelX needs for narcolepsy and ALS?
NewcelX Ltd. has announced the publication of its international DOXA compound patent in China, further securing intellectual property protection for its cross-domain pipeline in neurology and metabolic diseases. The patent application covers a new class of small molecules derived from quinazoline, benzothiazine, and benzoxazine scaffolds. These compounds are designed to modulate orexin signaling, neuroinflammation, and